nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 481 participants.
Also called NCT01824394
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 481 participants
- Sponsor
- Registry
-
NCT01824394
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Terminated
Technical summary
Registry record NCT01824394. Randomized; single masking; primary purpose treatment. Start 2013-04-01 (actual); primary completion 2017-11-26 (actual). Results posted on 2018-12-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Device)
- nMARQ Navigation Catheters
- Intervention (Device)
- NaviStar ThermoCool Catheters
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct01824394- Content hash
7e1f725cd1bdb390dee60f67e71c90bfa9211f5464bcbdd9ae0c711904487038